Chris Cleary - Feb 3, 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Director
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Stock symbol
OBIO
Transactions as of
Feb 3, 2025
Transactions value $
$0
Form type
4
Date filed
2/5/2025, 04:16 PM
Previous filing
Feb 5, 2025

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option (Right to Buy) Award $0 +30.7K $0.00 30.7K Feb 3, 2025 Common Stock 30.7K $5.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on February 3, 2025. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (1) 2,987 RSUs vest on June 24, 2025 and (2) the remaining 7,168 RSUs vest in three equal, annual installments beginning on February 3, 2026, subject to the Reporting Person's continuous service through such dates.
F2 The stock options shall vest as follows: (1) 9,223 stock options shall vest on June 24, 2025 and (2) the remaining 21,519 stock options shall vest in three equal, annual installments beginning on February 3, 2026, subject to the Reporting Person's continuous service through such date.